Symbols

MASS

908 Devices·NASDAQ

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 2

Ample Liquidity

High Gross Profit Margin

Gap Down

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About MASS

908 Devices Inc.

A developer of analytical devices for chemical and biomolecular analysis and field forensic devices

Industry

Life Science Tools and Services

Established Date

02/10/2012

Listing Date

12/18/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

172

Fiscal Year Ends

12-31

Website

www.908devices.com

Security Type

Common stock

Office address

44 Third Avenue Burlington MA 01803

Business

Introduction

908 Devices Inc., was incorporated in Delaware on February 10, 2012. The Company is a commercial-grade technology company that provides a suite of dedicated handheld and desktop mass spectrometers for the detection of unknown and invisible substances in a wide range of markets, including life science research, bioprocessing, industrial biotechnology, forensics and adjacent markets.

Company Financials

EPS

MASS has released its 2025 Q4 earnings. EPS was reported at 0.1, versus the expected -0.08, beating expectations. The chart below visualizes how MASS has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

MASS has released its 2025 Q4 earnings report, with revenue of 17.38M, reflecting a YoY change of 21.17%, and net profit of 4.17M, showing a YoY change of 121.46%. The Sankey diagram below clearly presents MASS's revenue sources and cost distribution.